Antitumor activity of the alkylating oligopeptides J1 (L-melphalanyl-p-L-fluorophenylalanine ethyl ester) and P2 (L-prolyl-m-L-sarcolysyl-p-L-fluorophenylalanine ethyl ester): comparison with melphalan-Reference-Cited by-同舟云学术

Antitumor activity of the alkylating oligopeptides J1 (L-melphalanyl-p-L-fluorophenylalanine ethyl ester) and P2 (L-prolyl-m-L-sarcolysyl-p-L-fluorophenylalanine ethyl ester): comparison with melphalan

Published:2003-09 Issue:8 Volume:14 Page:617-624
ISSN:0959-4973
Container-title:Anti-Cancer Drugs
language:en
Short-container-title:Anti-Cancer Drugs

Author:

Gullbo Joachim,Dhar Sumeer,Luthman Kristina,Ehrsson Hans,Lewensohn Rolf,Nygren Peter,Larsson Rolf

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cancer Research,Pharmacology (medical),Pharmacology,Oncology

Reference30 articles.

1. Peptichemio versus melphalan (L-PAM) in advanced breast cancer

2. Peptichemio: A New Oncolytic Drug in Combination with Vincristine and Prednisolone in the Treatment of Non-Hodgkin Lymphomas

3. A phase II study of peptichemio in advanced breast cancer

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The emerging role of melflufen and peptide-conjugates in multiple myeloma;Current Opinion in Oncology;2024-08-22

2. A review: FDA-approved fluorine-containing small molecules from 2015 to 2022;European Journal of Medicinal Chemistry;2023-11

3. Tinker, Tailor, Soldier, Spy: The Diverse Roles That Fluorine Can Play within Amino Acid Side Chains;Molecules;2023-08-22

4. A rapid intracellular enrichment of alkylating payload is essential for melphalan flufenamide potency and mechanism of action;Biochemical and Biophysical Research Communications;2023-05

5. Melphalan: Recent insights on synthetic, analytical and medicinal aspects;European Journal of Medicinal Chemistry;2022-08